Location History:
- Kyunggki-do, KR (2002)
- Kyunggi-do, KR (2002)
Company Filing History:
Years Active: 2002
Title: Innovations of Jun-Yong Ha
Introduction
Jun-Yong Ha is a notable inventor based in Kyungki-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cyclooxygenase-2 (COX-2) for therapeutic purposes. With a total of 2 patents, his work is recognized for its potential impact on treating inflammation and related disorders.
Latest Patents
Jun-Yong Ha's latest patents include innovative compounds that serve as COX-2 inhibitors. The first patent describes a novel class of 4,5-diaryl-3(2H)-furanone derivatives, which exhibit strong and selective inhibition of COX-2 over COX-1. This invention is particularly useful for treating inflammation, inflammation-associated disorders, and COX-2 mediated diseases. The second patent focuses on diarylbenzopyran derivatives, which also demonstrate excellent selective inhibition of cyclooxygenase-2. These compounds, along with their pharmaceutically acceptable salts, show promise in the development of effective anti-inflammatory medications.
Career Highlights
Jun-Yong Ha is currently associated with Pacific Corporation, where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and a focus on creating effective therapeutic solutions.
Collaborations
He collaborates with esteemed colleagues, including Yung Hyup Joo and Chang Hoon Lee, to further enhance the scope and impact of his research. Their combined expertise contributes to the successful development of new pharmaceutical compounds.
Conclusion
Jun-Yong Ha's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work in developing COX-2 inhibitors has the potential to lead to effective treatments for various inflammatory conditions.